Start for free
Start for free
Agent Capital logo

Agent Capital

North America, Massachusetts, United States, Cambridge

Description

A biotech venture capital firm.

Investor Profile

Agent Capital has made 48 investments, with 5 in the past 12 months and 8% as lead.

Stage Focus

  • Series B (40%)
  • Series A (25%)
  • Series C (15%)
  • Series Unknown (10%)
  • Seed (6%)
  • Post Ipo Equity (2%)
  • Series D (2%)

Country Focus

  • United States (92%)
  • France (4%)
  • United Kingdom (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Genetics
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Agent Capital frequently co-invest with?

Wellington Partners
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 6
Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 8
MRL Ventures Fund
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
CH
Cowen Healthcare Investments
North America, New York, United States, New York
Co-Investments: 5
Tellus BioVentures
Tellus BioVentures
North America, New York, United States, Florida
Co-Investments: 6
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 5
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 6

Which angels does Agent Capital often collaborate with?

AP
Anthony Pompliano
North America, California, United States, San Francisco
Shared Deals: 1
MR
Michael Rabil
North America, California, United States, San Francisco
Shared Deals: 1
PR
Paul Rabil
North America, Maryland, United States, Baltimore
Shared Deals: 1
AR
Austin Rief
North America, New York, United States, New York
Shared Deals: 1
NB
Nikita Bier
North America, California, United States, San Francisco
Shared Deals: 1
CS
Codie Sanchez
North America, Texas, United States, Austin
Shared Deals: 1
JD
Jonathan Downey
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Agent Capital?

Hone Health

New York, New York, United States

Hone Health is a telehealth clinic that offers hormone optimization and wellness therapies for both men and women.

Health Care
Series AJan 28, 2025
Amount Raised: $33,000,000
TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Foresight Diagnostics

Denver, Colorado, United States

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

BiotechnologyHealth CarePharmaceutical
Series BJul 30, 2024
Amount Raised: $33,000,000
āshibio

Brisbane, California, United States

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

BiotechnologyMedical DeviceTherapeutics
Series AJun 20, 2024
Amount Raised: $40,000,000
Cerevance

Boston, Massachusetts, United States

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series BApr 25, 2024
Amount Raised: $47,000,000
Q32 Bio

Cambridge, Massachusetts, United States

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityMar 25, 2024
Amount Raised: $42,000,000
Cantai Therapeutics

Philadelphia, Pennsylvania, United States

Cantai Therapeutics operates as a developer of drug candidates.

Life ScienceMedical
SeedNov 20, 2023
Amount Raised: $700,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
Jana Care

Boston, Massachusetts, United States

Jana Care develops and manufactures a novel-connected blood diagnostic device.

Health CaremHealthPersonal Health
Series BNov 8, 2023
Amount Raised: $6,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series CSep 5, 2023
Amount Raised: $90,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator